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ISSCR: President’s NoteNew Initiatives for the ISSCRThe chief mission of the International Society for StemCell
Research (ISSCR) is to promote the highest standards of
scientific communication among practitioners of the
emerging field of stem cell biology and regenerative med-
icine and to develop a fertile environment that supports
the growth of the field. To promote professional education
and communication, the Society has organized five spec-
tacularly successful annual meetings, the last three of
which hosted on average over 2000 scientists from all
over the world. The 2008 annual meeting program com-
mittee, chaired by Ihor Lemischka, is busily planning the
6th ISSCR Annual Meeting to be held on June 11–14th,
2008 in Philadelphia.
With a successful scientific meeting series established,
the ISSCR leadership is now exploring other avenues to
advance the cause of stem cell research. Following the
lead of the special task force that produced the ISSCR
Guidelines for the Conduct of Human Embryonic Stem
Cell Research, the ISSCR is now convening another task
force to explore the unique challenges of translating
stem cell biology into clinical trials. The ISSCR Task Force
on the Clinical Translation of Stem Cells will be chaired by
Professor Olle Lindvall of Lund University, Sweden, a pio-
neering investigator in cell transplants for neurologic dis-
ease, and cochaired by bioethicist Insoo Hyun of Case
Western Reserve University. The task force will examine
the scientific, ethical, and regulatory aspects of bringing
novel stem cell therapies to the clinic.
As pressure mounts to advance stem cell science
quickly toward clinical applications, it is essential for the
scientific and medical community to step back and take
an in-depth look at the challenges facing the translation
of stem cell biology. In part because scientists have justi-
fied their calls for more research funding with promises of
future medical benefit, and in part because there aremany
patients desperate for treatments for a host of intractable
conditions, there exists a receptive audience for the proc-
lamation that stem cells will cure all ills. Medical clinics are
springing up in locations that allow them to operate with-
out appreciable regulatory oversight, creating adangerous
form ofmedical tourism that threatens the health—and the
finances—of unwitting patients. Even within respectable
institutions operating under the most conscientious of in-
stitutional oversight, clinical trials have proceeded on the
basis of scant preclinical substantiation, prompting con-
cerns among stem cell scientists that some translational
clinicians are being too aggressive. Given that stem cell
transplants of any sort other than blood represent a rela-
tively new form of therapy, translating stem cell science
into the clinic raises new challenges, questions, and calls
for us to proceed with caution. What standards of preclin-
ical efficacy should be met before moving to patients?
Should safety be the sole concern? Are there potentially
unique toxicities for stem cell treatments? Does there
need to be a unique form of oversight of stem cell-basedclinical trials? What role if any should the ISSCR play in
establishing international standards for clinical translation,
in promoting clinical translation, in regulating clinical trans-
lation? The ISSCR Task Force on the Clinical Translation
of Stem Cells will sift through these many questions, for-
mulate a mission and scope, and over the course of the
coming year delve into the issues. The task force will pres-
ent a first report to the membership at the annual meeting
in June 2008.
The field of stem cell research is growing rapidly, and
the ISSCR leadership perceives a need to examine itself
and its mission, and to set a course for the future that
will best serve the expanding base of scientists involved
in stem cell research worldwide. Increasingly, regional
groups are looking to organize local memberships and
to sponsor regional meetings. When the annual meetings
are held at one locale, the cost of travel is prohibitively ex-
pensive for many ISSCR members in distant locales. How
can the ISSCR leadership ensure a fair international repre-
sentation at annual meetings? Different countries are op-
erating under a patchwork quilt of regulations, with vastly
differing political climates and funding opportunities for
scientists. How can the ISSCR best ensure that the sci-
ence can continue to expand vigorously worldwide? And
the entire field is facing the challenge of maintaining scien-
tific rigor in the face of a public that is clamoring for rapid
clinical translation of stem cell studies. How might the
ISSCR best position itself for the future? How will the
ISSCR secure the funds necessary to maintain its rele-
vance worldwide, and to tackle new initiatives?
In order to face these and other rapidly emerging
challenges to the mission of the ISSCR, the leadership is
recruiting a group of individuals from outside the stem
cell research community who share a deep commitment
to the goals of the ISSCR, andwhowill help formulate a co-
ordinated strategy for the ISSCR for the coming decade.
The Global Advisory Council will comprise energetic indi-
viduals from the public and private sectors who together
with members of the ISSCR scientific community will
help shape priorities for the ISSCR. This external group
will complement the leadership and direction provided
by our Board of Directors, a group of leading international
scientists elected by the ISSCR membership. Robert
Klein, the driving force behind the California Institute for
Regenerative Medicine (CIRM), has agreed to be a found-
ing member of the Council and has been instrumental in
helping the ISSCR to formulate plans for the council and
to recruit its initial members.
The Global Advisory Council will convene its first annual
meeting in March 2008. A planning committee is at work
to organize formal presentations at the meeting to explore
a variety of issues, including the following: the current
state of stem cell science—recent breakthroughs and
critical barriers to future progress; the latest ethical frame-
works that govern the conduct of stem cell research; theCell Stem Cell 1, November 2007 ª2007 Elsevier Inc. 513
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cell research. Based on the current state of stem cell sci-
ence, the Advisory Council will help the ISSCR leadership
to plot a course for the future, which we anticipate will
include a concrete plan to ensure that the ISSCR can
operate on a firm financial footing in the years to come.
The charge of the Global Advisory Council will be to as-
sist the ISSCR in promoting the goals of stem cell research
and clinical application through coordinated public edu-
cation and effective public relations, as well as govern-
mental and philanthropic support. The ISSCR is seeking
input from its membership into the composition and
charge of the Global Advisory Council. If you have ideas
for individuals who would make energetic and influential
members of the Council, or want to express your ideas
for important topics for the Council to consider at its
annual meeting, please contact the ISSCR Executive
Director, Nancy Witty (nwitty@isscr.org).
In all ISSCR undertakings, the president draws from the
combined expertise and counsel of the Board of Directors,
which currently numbers 21 members from 8 countries.
The directors are your representatives and make policy
decisions that influence the bearing the Society takes.
As an ISSCRmember you are eligible to nominate individ-
uals for positions for Board of Directors and vote in the514 Cell Stem Cell 1, November 2007 ª2007 Elsevier Inc.annual general membership election. Each year, positions
become available on the Board of Directors, including the
office of vice president. The vice president is committed to
a three year term that culminates in a year as president of
the ISSCR; after a year in office as vice president, he or
she becomes the president elect and, in the third year,
the president. Serving the Society as an officer constitutes
a significant commitment of time and carries the responsi-
bility of representing the stem cell field in the eyes of the
public, government officials, and fellow scientists from
other fields. This is a challenging and yet potentially re-
warding experience, and an opportunity tomold the shape
and direction of a new and exciting discipline.
We are currently calling for nominations of individuals
for Board of Directors positions that will become avail-
able in June 2008. The ISSCR Nominations Committee,
chaired by Paul Simmons, will review eligible nominees
and develop a slate for the annual general membership
election in February 2008, with an emphasis on scientific
authority and to keep the overall international diversity of
the board. Members, we encourage you to think about
who you want as your leadership. Please send your nom-
inations to Nancy Witty, Executive Director (nwitty@isscr.
org). Nominations will be accepted until midnight (CST) on
December 4, 2007.
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